The Rothmund-Thomson syndrome is a rare syndrome which is believed to be inherited in an autosomal pattern. Poikiloderma of the face and extremities is a characteristic feature. Besides this, less common aspects have been reported like alopecia, cataracts, short stature, musculoskeletal/bone defects or small hands, hypogonadism, abnormal teeth, dysplastic nails, anhidrosis and a high incidence of cutaneous and non-cutaneous malignancies. We present a patient with the Rothmund-Thomson syndrome together with anhidrosis and multiple infections of the upper and lower respiratory tract. Investigation of immunological function revealed a low total number of T lymphocytes with a slightly depressed reactivity. Immunoglobulins were markedly increased.

Keywords:
Rothmund-Thomson syndrome, Anhidrosis, Lung infections
1.
Berg E, Chuang TY, Cripps D: Rothmund-Thomson syndrome: A case report, phototesting and literature review. J Am Acad Dermatol 1987;17:332–338.
2.
Vennos EM, Collins M, James WD: Rothmund-Thomson syndrome: Review of the world literature. J Am Acad Dermatol 1992; 27:750–759.
3.
Kerr B, Ashcroft GS, Scott D, Horan HA, Ferguson MWJ, Donnai D: Rothmund-Thomson syndrome: Two case reports show heterogeneous cutaneous abnormalities, an association with genetically programmed ageing changes, and increased chromosomal radiosensitivity. J Med Genet 1996;33:928–934.
4.
Starr DG, McClure JP, Connor JM: Non-dermatological complications and genetic aspects of the Rothmund-Thomson syndrome. Clin Genet 1985;27:102–104.
5.
Lessem J, Bjerre I, Forslund M: Epilepsy and myopathy in a patient with Rothmund-Thomson’s syndrome. Acta Med Scand 1980;207: 237–239.
6.
Kirkham TH, Werner EB: The ophthalmic manifestations of Rothmund’s syndrome. Can J Ophthalmol 1975;10:1–14.
7.
Bechelli LM, Pagnano PM, Tanaka AM, Trad ES, Pimenta WP: Rothmund’s syndrome. Ann Dermatol Venereol 1984;111:667–668.
8.
Moss C: Rothmund-Thomson syndrome: A report of two patients and a review of the literature. Br J Dermatol 1990;122:821–829.
9.
Lewis MB: Rothmund-Thomson syndrome. Aust J Dermatol 1966;8:254–255.
10.
Roth DE, Campisano LL, Callen JP, Hersch JH, Yusk JW: Rothmund-Thomson syndrome: A case report. Pediatr Dermatol 1989;6: 321–324.
11.
Aydemir EH, Onsun N, Ozan S, Hatemi HH: Rothmund-Thomson syndrome with calcinosis universalis. Int J Dermatol 1988;27: 591–592.
12.
Limon J, Filipiuk J, Nedoszytko B, Mrozek K, Castren M, Larramendy M, Roszkiewicz J: X-linked anhidrotic ectodermal dysplasia and de novo t(X;1) in a female. Hum Genet 1991; 87:338–340.
13.
Kindler T: Congenital poikiloderma with traumatic bulla formation and progressive cutaneous atrophy. Br J Dermatol 1954;66: 104–111.
14.
Salamon T, Bogdanovic B, Lazovic O: Über einen Fall von Thomson-Syndrom und Epidermolysis-bullosa-dystrophica-artigen Hautveränderungen. Arch Klin Exp Dermatol 1966; 225:194–200.
15.
Alper JC, Baden HP, Goldsmith LA: Kindler’s syndrome. Arch Dermatol 1978;114:457.
16.
Weary PE, Manley WF, Graham GF: Hereditary acrokeratotic poikiloderma. Arch Dermtol 1971;103:409–422.
17.
Taylor WB: Rothmund’s syndrome – Thomson’s syndrome. Arch Dermatol 1957;75: 236–244.
18.
Hallman N, Patiala R: Congenital poikiloderma atrophicans vasculare in a mother and her son. Acta Dermatol Venereol 1951;1: 401–406.
19.
Davies MG: Rothmund-Thomson syndrome and malignant disease (letter). Clin Exp Dermatol 1982;7:455.
20.
Haneke E, Gutschmidt E: Premmature multiple Bowen’s disease in poikiloderma congenitale with warty hyperkeratosis. Dermatologica 1979;158:384–388.
21.
Van Hees CL, Van Duinen CM, Bruijn JA, Vermeer BJ: Malignant eccrine poroma in a patient with the Rothmund-Thomson syndrome. Br J Dermatol 1996;4:813–815.
22.
Dick DC, Morley WN, Watson JT: Rothmund-Thomson syndrome and osteogenic sarcoma. Clin Exp Dermatol 1982;7:119–123.
23.
Rebaud P, David L, Plauchu H, Châtelain P, Moulin G, François R: A familial case of Rothmund-Thomson: A case in favor of uniqueness of the syndrome associated with osteosarcoma. Pédiatrie 1985;40:487–492.
24.
Tokunaga M, Sato K, Funagama K, Wahamatsu E: Rothmund-Thomson syndrome associated with osteosarcoma. J Jpn Orthop Assoc 1976;50: 287–293.
25.
Kozlowski K, Scougall JS, Oates RK: Osteosarcoma in a boy with Rothmund-Thomson syndrome. Pediatr Radiol 1980;10:42–45.
26.
Baro PR, Bastart FM, Batrina JR, Mateo JM, Vidal MT: Case report 529: Osteeosarcoma of calcaneus with Rothmund-Thomson syndrome. Skeletal Radiol 1989;18:136–139.
27.
el-Khoury JM, Haddad SN, Atallah NG: Osteosarcomatosis with Rothmund-Thomson syndrome. Br J Radiol 1997;70:215–218.
28.
Cumin I, Cohen JY, David A, Mechinaud F, Avet-Loiseau H, Harousseau JL: Rothmund-Thomson syndrome and osteosarcoma. Med Pediatr Oncol 1996;26:414–416.
29.
Werder EA, Murset G, Illig R, Prader A: Hypogonadism and parathyroid adenoma in congenital poikiloderma (Rothmund-Thomson syndrome). Clin Endocrinol 1975;4:75–82.
30.
Diem E: The Rothmund-Thomson syndrome – A case report. Hautarzt 1975;26:425–429.
31.
Shinya A, Nishigori C, Moriwaki S, Takebe H, Kubota M, Ogino A, Imamura S: A case of Rothmund-Thomson syndrome with reduced DNA repair capacity. Arch Dermatol 1993; 129:332–336.
32.
Barrut D, Goujon-Henry C, Thomas L, Vasseur F, Moulin G: Poikilodermie congénitale type Thomson avec anomalie de l’excision-réparation de l’ADN. Ann Dermatol Vénéréol 1993; 120:755–758.
33.
Prache-de-Carrere B, Teillac-Hamel D, Capesius C, Castelneau JP, Robert C, Fraitag S, de Prost Y: Syndrome de Rothmund-Thomson avec anomalie de l’excision-réparation de l’ADN. Ann Dermatol Vénéréol 1996;123: 395–397.
1998
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.